Although the success of FMT requires donor bacteria to engraft in the patient’s gut, the forces governing engraftment in humans are unknown. Here we use an ongoing clinical experiment, the treatment of recurrent Clostridium difficile infection, to uncover the rules of engraftment in humans.
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(18)30038-6?_returnURL=https%3A%2F2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1931312818300386%3Fshowall%3Dtrue